查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402578

Sildenafil药品市场：按药物类型、按适应症、按分销管道、按剂型、按地区

Sildenafil Drug Market, By Drug Type, By Indication, By Distribution Channel, By Dosage Form, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

Sildenafil药品市场规模预计将从 2023 年的 29 亿美元增至 2030 年的 45.6 亿美元，预测期内复合年增长率为 6.7%。

报告范围 报告详情
基准年 2022年 2023年市场规模 29亿美元
实际资料 2018-2021 预测期 2023-2030
预测期复合年增长率 6.70% 2030年市场规模预测 45.6亿美元
图 1. 2023 年Sildenafil药品市场占有率(%)，依地区划分
西地那非药品市场-IMG1

Sildenafil，俗称“蓝色小锭剂”，是一种广泛用于治疗勃起功能障碍 (ED) 的药物。它属于称为 5 型磷酸二酯酶 (PDE5) 抑制剂的药物类别，以商品名威而钢 (Viagra) 销售。Sildenafil可以放鬆阴茎血管的平滑肌，增加血流量，最终促进勃起。

自 20 世纪 90 年代末推出以来，Sildenafil彻底改变了 ED 治疗领域，为全球数百万男性带来了缓解。Sildenafil已成为难以实现或维持勃起的人的首选药物，提供了一种有效的解决方案，改变了许多人的生活。

市场动态：

Sildenafil药品市场预计在预测期内将出现显着成长。这一增长的主要驱动因素包括全球勃起功能障碍的盛行率不断上升、人口老化以及性健康意识的提高。

然而，市场也存在挑战。一个重要的抑制因素是市场上存在仿冒品Sildenafil产品，这可能会对消费者造成严重的健康风险。监管机构和製药公司正在努力打击假药。

儘管存在这些挑战，Sildenafil市场仍然存在一些机会。口溶锭和咀嚼片等创新剂型的开发增加了患者的便利性并简化了给药。Sildenafil学名药的出现预计将透过使药物更便宜和更容易获得来推动市场成长。

本研究的主要特点

  • 本报告对Sildenafil製药市场进行了详细分析，包括以 2022 年为基准年的 2023-2030 年预测期内的市场规模（以十亿美元为单位）和年复合成长率（CAGR%）。
  • 这项研究探讨了各个细分市场的潜在商机，并为该市场提出了有吸引力的投资提案。
  • 它提供了有关市场驱动因素、抑制因素因素、机会、新产品发布和核准、市场趋势和驱动因素、区域前景、主要企业采取的竞争策略等的重要考察。
  • 本报告提供了全球Sildenafil药品市场主要企业的概况，包括他们的公司背景、产品系列、主要绩效、财务表现和策略。
  • 研究包括辉瑞、梯瓦製药、Aurobindo Pharma、Alembic Pharmaceuticals、Torrent Pharmaceuticals、Lupin、Dr Reddy's Laboratories、Zydus Cadila、Amneal Pharmaceuticals、Hetero、Apotex、Mylan、Ajanta Pharma、Sun Pharmaceutical、Clila、诺华，包括 Lillan主要企业。
  • 本报告提供的见解使行销人员和负责人能够就产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和财务分析师，都将从本报告的调查结果中受益。
  • 相关人员可以利用用于分析Sildenafil药品市场的策略矩阵来促进决策流程。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
  • 勃起功能障碍盛行率增加
    • 抑制因素
  • 副作用和安全问题
    • 机会
  • 新型药物输送系统的开发
  • 主要亮点
  • 监管场景
  • 最近的趋势
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 合併、收购和广告合作

第四章Sildenafil药品市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章Sildenafil药物市场，依药物类型，2018-2030

  • 品牌药品
  • 学名药
  • 成药

第 6 章 2018-2030 年Sildenafil药品市场（依适应症）

  • 勃起功能障碍
  • 肺动脉高血压
  • 良性摄护腺增生症
  • 其他（早洩、高山症）

第7章Sildenafil药品市场，依通路，2018-2030

  • 医院药房
  • 零售药房
  • 网路药房
  • 其他（诊所、通讯药局）

第8章Sildenafil药品市场，按剂型，2018-2030

  • 药片
  • 口服果冻
  • 注射
  • 其他（混悬液、胶囊）

第9章Sildenafil药品市场，依地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 中部非洲
  • 北非

第10章竞争形势

  • 公司简介
    • Pfizer
    • Teva Pharmaceuticals
    • Aurobindo Pharma
    • Alembic Pharmaceuticals
    • Torrent Pharmaceuticals
    • Lupin
    • Reddy's Laboratories
    • Zydus Cadila
    • Amneal Pharmaceuticals
    • Hetero
    • Apotex
    • Mylan
    • Ajanta Pharma
    • Sun Pharmaceutical
    • Cipla
    • Novartis
    • Eli Lily
    • Sanofi
    • Bayer
    • GlaxoSmithKline

第11章 章节

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6336

The sildenafil drug market size is expected to reach US$ 4.56 Bn by 2030, from US$ 2.90 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 6.7% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 2.90 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.70% 2030 Value Projection: US$ 4.56 Bn
Figure 1. Sildenafil Drug Market Share (%), By Region, 2023
Sildenafil Drug Market - IMG1

Sildenafil which is commonly known as the "little blue pill," is a widely used drug primarily used to treat erectile dysfunction (ED). It belongs to the class of medications called phosphodiesterase type 5 (PDE5) inhibitors and is marketed under the brand name Viagra. Sildenafil works by relaxing the smooth muscles of the blood vessels in the penis, thereby allowing for increased blood flow and ultimately facilitating an erection.

Since its introduction in the late 1990s, sildenafil has revolutionized the field of ED treatment, providing relief to millions of men worldwide. It has become the go-to medication for individuals experiencing difficulties in achieving and maintaining an erection, thereby offering an effective solution that has transformed the lives of many.

Market Dynamics:

The sildenafil drug market is expected to witness significant growth in the forecast period. The key drivers for this growth include the increasing prevalence of erectile dysfunction worldwide, the growing aging population, and the rising awareness regarding sexual health.

However, the market has also challenges. The significant restraint is the presence of counterfeit sildenafil products in the market, which can pose serious health risks to consumers. Regulatory bodies and pharmaceutical companies are making efforts to crack down on counterfeit drugs.

Despite these challenges, the sildenafil market presents several opportunities. The development of innovative dosage forms, such as orally disintegrating tablets and chewable tablets, offers convenience and ease of administration for patients. The emergence of generic versions of sildenafil is expected to drive the market growth by making the drug more affordable and accessible.

Key Features of the Study:

  • This report provides an in-depth analysis of the sildenafil drug market, including market size (in US$ Bn) and compound annual growth rate (CAGR %) for the forecast period of 2023-2030, with 2022 as the base year
  • The study explores potential revenue opportunities across different market segments and presents attractive investment propositions for this market
  • It offers key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • The report profiles key players in the global sildenafil drug market, highlighting their company background, product portfolio, key accomplishments, financial performance, and strategies
  • The study includes key companies such as Pfizer, Teva Pharmaceuticals, Aurobindo Pharma, Alembic Pharmaceuticals, Torrent Pharmaceuticals, Lupin, Dr Reddy's Laboratories, Zydus Cadila, Amneal Pharmaceuticals, Hetero, Apotex, Mylan, Ajanta Pharma, Sun Pharmaceutical, Cipla, Novartis, Eli Lily, Sanofi, Bayer, and GlaxoSmithKline.
  • The insights provided by this report would enable marketers and management authorities to make informed decisions regarding product launches, upgrades, market expansion, and marketing tactics
  • Various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts, would benefit from the findings of this report
  • Stakeholders can leverage the strategy matrices used in analyzing the sildenafil drug market to facilitate decision-making processes

Detailed Segmentation:

  • Sildenafil Drug Market, By Drug Type
    • Branded Drugs
    • Generic Drugs
    • Over The Counter Drugs
  • Sildenafil Drug Market, By Indication
    • Erectile Dysfunction
    • Pulmonary Arterial Hypertension
    • Benign Prostatic Hyperplasia
    • Others (Premature Ejaculation, Altitude Sickness)
  • Sildenafil Drug Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Others (Clinics, Mail Order Pharmacies)
  • Sildenafil Drug Market, By Dosage Form
    • Tablets
    • Oral Jellies
    • Injections
    • Others (Suspensions, Capsules)
  • Sildenafil Drug Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in Sildenafil Drug Market:
    • Pfizer
    • Teva Pharmaceuticals
    • Aurobindo Pharma
    • Alembic Pharmaceuticals
    • Torrent Pharmaceuticals
    • Lupin
    • Reddy's Laboratories
    • Zydus Cadila
    • Amneal Pharmaceuticals
    • Hetero
    • Apotex
    • Mylan
    • Ajanta Pharma
    • Sun Pharmaceutical
    • Cipla
    • Novartis
    • Eli Lily
    • Sanofi
    • Bayer
    • GlaxoSmithKline

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Indication
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Dosage Form
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of erectile dysfunction
    • Restraints
  • Adverse effects and safety concerns
    • Opportunities
  • Development of novel drug delivery system
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, ad Collaborations

4. Sildenafil Drug Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Sildenafil Drug Market, By Drug Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Branded Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Generic Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Over The Counter Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Sildenafil Drug Market, By Indication, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Erectile Dysfunction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Pulmonary Arterial Hypertension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Benign Prostatic Hyperplasia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others (Premature Ejaculation, Altitude Sickness)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Sildenafil Drug Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others (Clinics, Mail Order Pharmacies)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Sildenafil Drug Market, By Dosage Form, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Oral Jellies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Injections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others (Suspensions, Capsules)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Sildenafil Drug Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
  • South Africa
  • Central Africa
  • North Africa

10. Competitive Landscape

  • Company Profile
    • Pfizer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Teva Pharmaceuticals
    • Aurobindo Pharma
    • Alembic Pharmaceuticals
    • Torrent Pharmaceuticals
    • Lupin
    • Reddy's Laboratories
    • Zydus Cadila
    • Amneal Pharmaceuticals
    • Hetero
    • Apotex
    • Mylan
    • Ajanta Pharma
    • Sun Pharmaceutical
    • Cipla
    • Novartis
    • Eli Lily
    • Sanofi
    • Bayer
    • GlaxoSmithKline
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us